The Effect of an Anti-obesity Drug, Semaglutide, as Treatment in New-onset Idiopathic Intracranial Hypertension (IIH) Compared to Standard Weight Management (Dietician) With Regards to Change in Weight and Intracranial Pressure

NCT06027567 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

38

Enrollment

OTHER

Sponsor class

Conditions

Idiopathic Intracranial Hypertension
Intracranial Pressure
Obesity
Pseudotumor Cerebri Syndrome
Papilledema
Weight Loss

Interventions

DRUG: Semaglutide
DIETARY_SUPPLEMENT: Very Low Calorie Diet
BEHAVIORAL: Dietician counselling

Sponsor

Rigmor Højland Jensen

Collaborators

[object Object]
[object Object]
[object Object]